J&J Subsidiary Files for Bankruptcy to Advance $8 Billion Talc Settlement
The J&J Red River Talc unit made its filing in the U.S. Bankruptcy Court for the Southern District of Texas. J&J faces lawsuits from more than 62,000 claimants who alleged that its baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers.
J&J's Subsidiary Red River Talc Files For Chapter 11 Bankruptcy To Resolve Ovarian Cancer Claims
Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11
Johnson & Johnson unit seeks third Chapter 11 bankruptcy filing to settle talc claims
A Johnson & Johnson (NYSE:JNJ) subsidiary, Red River Talc, that has been formed to handle claims related to the healthcare giant's talc-based products, filed a voluntary prepackaged Chapter 11 bankruptcy case Friday to resolve current and future claims linked to ovarian cancer.
J&J Unit Seeks Chapter 11 Bankruptcy for Third Time Over Baby Powder Suits
Johnson & Johnson said it received overwhelming support for a roughly $8 billion settlement of claims that its talc-based baby powder caused cancer, a key step as the company makes its third attempt to resolve thousands of lawsuits in bankruptcy court.
Johnson & Johnson Files Third Bankruptcy Case Seeking to End Talc Lawsuits
The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed attempts.
AbbVie Gets CHMP Backing for Elahere in Ovarian Cancer
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
Early detection and recognizing symptoms are key in fighting ovarian cancer
Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...
Medpage Today on MSN4d
Rucaparib-Nivolumab Maintenance Not the Answer in Newly Diagnosed Ovarian Cancer
Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...
Scientists Discover Over 3,000 Genetic Variants That Could Significantly Increase Your Risk of Ovarian and Breast Cancer
New reserach has identified particular genetic mutations that elevate the risk of breast and ovarian cancers, aiding in ...
Cure Today1d
Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More
From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...
CW39 NewsFix15h
Ovarian Cancer Awareness month in September takes cancer symptoms to the B.E.A.C.H.
1 in 75 women develop ovarian cancer in their lifetime and Everyone with ovaries is at risk ...
Medscape1d
EMA Backs Approval of Elahere for Ovarian Cancer
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...
There's still a lot we don't know about ovarian cancer, says Colorado doctor
As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...
The American Journal of Managed Care16h
Pan-Immune-Inflammation–Based Nomogram Predicts OS, PFS in Epithelial Ovarian Cancer
Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...
Medscape1d
Conjugated Antibodies: Emerging Star in Ovarian Cancer Tx
Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
Hundreds to participate in event to help fight ovarian cancer, support survivors
BLUE ASH, Ohio (WKRC) - An event this weekend in Blue Ash will help support cancer survivors. The Teal Power 5K Run and Walk to Fight Ovarian Cancer is Saturday. Everyone is invited to join hundreds ...